Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Serum 25-hydroxyvitamin D and risks of colon and rectal cancer in Finnish men.

Weinstein SJ, Yu K, Horst RL, Ashby J, Virtamo J, Albanes D.

Am J Epidemiol. 2011 Mar 1;173(5):499-508. doi: 10.1093/aje/kwq398. Epub 2011 Jan 19.

2.

Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study.

Weinstein SJ, Yu K, Horst RL, Parisi D, Virtamo J, Albanes D.

PLoS One. 2011;6(6):e20796. doi: 10.1371/journal.pone.0020796. Epub 2011 Jun 10.

3.

One-carbon metabolism biomarkers and risk of colon and rectal cancers.

Weinstein SJ, Albanes D, Selhub J, Graubard B, Lim U, Taylor PR, Virtamo J, Stolzenberg-Solomon R.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3233-40. doi: 10.1158/1055-9965.EPI-08-0459.

4.

Serum vitamin D and risk of bladder cancer.

Mondul AM, Weinstein SJ, Männistö S, Snyder K, Horst RL, Virtamo J, Albanes D.

Cancer Res. 2010 Nov 15;70(22):9218-23. doi: 10.1158/0008-5472.CAN-10-0985. Epub 2010 Oct 26.

5.

Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Weinstein SJ, Purdue MP, Smith-Warner SA, Mondul AM, Black A, Ahn J, Huang WY, Horst RL, Kopp W, Rager H, Ziegler RG, Albanes D.

Int J Cancer. 2015 Mar 15;136(6):E654-64. doi: 10.1002/ijc.29157. Epub 2014 Sep 2.

6.

A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.

Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, Giovannucci EL.

J Natl Cancer Inst. 2007 Jul 18;99(14):1120-9. Epub 2007 Jul 10.

PMID:
17623801
7.

Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer.

Anic GM, Weinstein SJ, Mondul AM, Männistö S, Albanes D.

PLoS One. 2014 Jul 18;9(7):e102966. doi: 10.1371/journal.pone.0102966. eCollection 2014.

8.

Serum vitamin D concentration and prostate cancer risk: a nested case-control study.

Ahn J, Peters U, Albanes D, Purdue MP, Abnet CC, Chatterjee N, Horst RL, Hollis BW, Huang WY, Shikany JM, Hayes RB; Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Project Team.

J Natl Cancer Inst. 2008 Jun 4;100(11):796-804. doi: 10.1093/jnci/djn152. Epub 2008 May 27.

9.

Iron and colorectal cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study.

Cross AJ, Gunter MJ, Wood RJ, Pietinen P, Taylor PR, Virtamo J, Albanes D, Sinha R.

Int J Cancer. 2006 Jun 15;118(12):3147-52.

10.

Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies.

Lee JE, Li H, Chan AT, Hollis BW, Lee IM, Stampfer MJ, Wu K, Giovannucci E, Ma J.

Cancer Prev Res (Phila). 2011 May;4(5):735-43. doi: 10.1158/1940-6207.CAPR-10-0289. Epub 2011 Mar 23.

11.

Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ, Weinstein SJ, McCullough ML, Purdue MP, Shu XO, Snyder K, Virtamo J, Wilkins LR, Yu K, Zeleniuch-Jacquotte A, Zheng W, Albanes D, Cai Q, Harvey C, Hayes R, Clipp S, Horst RL, Irish L, Koenig K, Le Marchand L, Kolonel LN.

Am J Epidemiol. 2010 Jul 1;172(1):81-93. doi: 10.1093/aje/kwq120. Epub 2010 Jun 18.

12.

Vitamin D-binding protein and pancreatic cancer: a nested case-control study.

Piper MR, Freedman DM, Robien K, Kopp W, Rager H, Horst RL, Stolzenberg-Solomon RZ.

Am J Clin Nutr. 2015 Jun;101(6):1206-15. doi: 10.3945/ajcn.114.096016. Epub 2015 Apr 22.

13.

Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men.

Arem H, Weinstein SJ, Horst RL, Virtamo J, Yu K, Albanes D, Abnet CC.

Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1178-84. doi: 10.1158/1055-9965.EPI-11-0153. Epub 2011 Apr 28.

14.

Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study.

Jenab M, Bueno-de-Mesquita HB, Ferrari P, van Duijnhoven FJ, Norat T, Pischon T, Jansen EH, Slimani N, Byrnes G, Rinaldi S, Tjønneland A, Olsen A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Kaaks R, Linseisen J, Boeing H, Bergmann MM, Trichopoulou A, Misirli G, Trichopoulos D, Berrino F, Vineis P, Panico S, Palli D, Tumino R, Ros MM, van Gils CH, Peeters PH, Brustad M, Lund E, Tormo MJ, Ardanaz E, Rodríguez L, Sánchez MJ, Dorronsoro M, Gonzalez CA, Hallmans G, Palmqvist R, Roddam A, Key TJ, Khaw KT, Autier P, Hainaut P, Riboli E.

BMJ. 2010 Jan 21;340:b5500. doi: 10.1136/bmj.b5500.

15.

Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial.

Stolzenberg-Solomon RZ, Hayes RB, Horst RL, Anderson KE, Hollis BW, Silverman DT.

Cancer Res. 2009 Feb 15;69(4):1439-47. doi: 10.1158/0008-5472.CAN-08-2694. Epub 2009 Feb 10.

16.

A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers.

Lim U, Freedman DM, Hollis BW, Horst RL, Purdue MP, Chatterjee N, Weinstein SJ, Morton LM, Schatzkin A, Virtamo J, Linet MS, Hartge P, Albanes D.

Int J Cancer. 2009 Feb 15;124(4):979-86. doi: 10.1002/ijc.23984.

17.

Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men.

Tangrea J, Helzlsouer K, Pietinen P, Taylor P, Hollis B, Virtamo J, Albanes D.

Cancer Causes Control. 1997 Jul;8(4):615-25.

PMID:
9242478
18.

Dietary and serum alpha-tocopherol, beta-carotene and retinol, and risk for colorectal cancer in male smokers.

Malila N, Virtamo J, Virtanen M, Pietinen P, Albanes D, Teppo L.

Eur J Clin Nutr. 2002 Jul;56(7):615-21.

19.

A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers.

Stolzenberg-Solomon RZ, Vieth R, Azad A, Pietinen P, Taylor PR, Virtamo J, Albanes D.

Cancer Res. 2006 Oct 15;66(20):10213-9.

20.

Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.

Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E.

Cancer Causes Control. 2004 Apr;15(3):255-65.

PMID:
15090720

Supplemental Content

Support Center